Source: European Journal of Pharmacology. Unidades: FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA, LINFOMA, NEOPLASIAS POR TIPO HISTOLÓGICO, CITOESQUELETO, FILAMENTOS CITOPLASMÁTICOS, ANTINEOPLÁSICOS, APOPTOSE, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, ESTUDOS DE COORTES
ABNT
SILVA, Jean Carlos Lipreri da et al. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, v. 987, p. 13 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.177161. Acesso em: 17 mar. 2025.APA
Silva, J. C. L. da, Lima, K., Ede, B., Lazarini, M., Vicari, H. P., Nogueira, F. L., et al. (2025). Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, 987, 13 . doi:10.1016/j.ejphar.2024.177161NLM
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 mar. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161Vancouver
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 mar. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161